SELLAS Life Sciences Group, Inc.: cash_and_restricted_cash
| Value | {"amount": 21131000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | SELLAS Life Sciences Group, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:26:31.937297+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d4e9c1a1-6392-4243-b98c-4e8232481fb3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001390478-24-000021 · Open the official SEC filing →Retrieved: 2026-08-19T13:26:31.937297+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001390478/cash-and-restricted-cash/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d4e9c1a1-6392-4243-b98c-4e8232481fb3
History
- no predecessors — first report